Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for raltegravir ...

Dr. Reddy’s (RDY) Laboratories and Senores Pharmaceuticals announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and therapeutically equivalent to STROMECTOL Tablets of ...

HYDERABAD, India, November 26, 2024--(BUSINESS WIRE)--Dr. Reddy's Laboratories, Inc. and Senores Pharmaceuticals, Inc. today announced the launch of Ivermectin Tablets USP, 3 mg, which is ...

Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for ...

This combination medication contains angiotensin II receptor blocker and diuretic, prescribed for high blood pressure.

This recall impacts the following product lot: See image of correct carton label: Clonazepam Orally Disintegrating Tablets, USP 0.25 mg 60-count carton, lot 550147301, expiration date August 2026 ...

Rivaroxaban Tablets USP are indicated to reduce the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, treatment of deep vein thrombosis (DVT), treatment of pulmonary ...

Global pharma major Lupin Limited on Tuesday announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug ...

2 The USP has approved ion chromatography (IC) with suppressed conductivity detection to quantify chloride content in these potassium chloride and potassium bicarbonate effervescent tablets. 2 The ...

Losartan Potassium and Hydrochlorothiazide Tablets USP in strengths of 50 mg/12.5 mg, 100 mg/12.5 mg, and 100 mg/25 mg received the green light from the US regulatory body. The annual US market ...

for Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg, 100 mg/12.5 mg, and 100 mg/25 mg. It is bioequivalent and therapeutically equivalent to the reference listed drug (RLD ...